首页> 外文期刊>Anaerobe >Antimicrobial susceptibility In vitro activity of oritavancin (LY333328), vancomycin, clindamycin, and metronidazole against Clostridium perfringens,Propionibacterium acnes, and anaerobic Gram-positive cocci
【24h】

Antimicrobial susceptibility In vitro activity of oritavancin (LY333328), vancomycin, clindamycin, and metronidazole against Clostridium perfringens,Propionibacterium acnes, and anaerobic Gram-positive cocci

机译:抗生素敏感性奥利万星(LY333328),万古霉素,克林霉素和甲硝唑对产气荚膜梭菌,痤疮丙酸杆菌和厌氧革兰氏阳性球菌的体外活性

获取原文
获取原文并翻译 | 示例
           

摘要

Using an agar dilution method, we determined the in vitro activity of oritavancin, vancomycin, clindamycin and metronidazole against 114 unique clinical isolates of Gram-positive anaerobes. MIC_(90)s (mug/mL) for oritavancin were as follows: Clostridium perfringens 1.0, Propionibacterium acnes 0.25, Peptostreptococcus anaerobius 0.25, Peptoniphilus asaccharolyticus 0.5, Finegoldia magna 0.25, Micromonas. micros 0.25, and Anaerococcus prevotii 0.25. On a weight basis, oritavancin is slightly more active than vancomycin against the strains tested. The oritavancin MICs are comparable to those previously reported against staphylococci and enterococci, Oritavancin shows excellent potential for treatment of infections containing Gram-positive anaerobes such as these.
机译:使用琼脂稀释法,我们确定了奥利万星,万古霉素,克林霉素和甲硝唑对114种革兰氏阳性厌氧菌的体外分离株的体外活性。奥利万星的MIC_(90)s(杯子/毫升)如下:产气荚膜梭菌1.0,痤疮丙酸杆菌0.25,厌氧链球菌0.25,嗜酸拟肽酶0.5,巨大细粉金枪鱼0.25,微单胞菌。 micros 0.25和厌氧链球菌0.25。以重量计,奥利万星对测试菌株的活性比万古霉素稍高。奥利万星MICs与以前报道的针对葡萄球菌和肠球菌的MIC相当,奥利万星在治疗含有此类革兰氏阳性厌氧菌的感染方面显示出极好的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号